PMU17 BUDGET IMPACT OF SECUKINUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE PSORIASIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS IN MEXICO
May 1, 2019, 00:00
10.1016/j.jval.2019.04.1180
https://www.valueinhealthjournal.com/article/S1098-3015(19)31372-5/fulltext
Title :
PMU17 BUDGET IMPACT OF SECUKINUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE PSORIASIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS IN MEXICO
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)31372-5&doi=10.1016/j.jval.2019.04.1180
First page :
Section Title :
Open access? :
No
Section Order :
10698